FDA Workshop: ERT Immune Response

On June 9, 2014, the Food and Drug Administration’s Center for Drug Evaluation and Research, in co-sponsorship with the National Organization for Rare Disorders (NORD), held a one-day public workshop entitled “Immune Responses to Enzyme Replacement Therapies: Role of Immune Tolerance Induction.” The purpose of this workshop was to provide a forum to discuss the role of immune tolerance induction in patients receiving replacement biological products.

Here is a transcript from that workshop.